Atypical Antipsychotics: Impact on Overall Health and Quality of Life
Author:
- 1 August 2002
- journal article
- Published by SAGE Publications in Journal of the American Psychiatric Nurses Association
- Vol. 8 (4_suppl) , S9-S17
Abstract
The use of antipsychotic medications for the treatment of schizophrenia requires a detailed assessment of patient history, including comorbidities and concomitant medications. Because all antipsychotics may produce a complex array of adverse effects, the patient’s drug therapy may lead to exacerbation of pre-existent health problems and impaired quality of life. The occurrence of drug-related side effects such as cardiac disturbances, diabetes, and obesity is important to document for these patients, especially if they are already at increased risk because of underlying disease, substance abuse, or smoking. Antipsychotics may also cause anticholinergic effects, gait disturbances, and excessive sedation, which are particularly important reactions to monitor in elderly patients. Psychiatric nurses need to be aware of the risk for these side effects in relation to patients’ new or ongoing medication so that potentially serious events can be recognized and corrected. Appropriate patient education about medication is also an important component in helping patients to recognize and manage side effects and to gain the most from their drug therapy.Keywords
This publication has 23 references indexed in Scilit:
- A Comparison of Risperidone and Haloperidol for the Prevention of Relapse in Patients with SchizophreniaNew England Journal of Medicine, 2002
- Guideline for the Prevention of Falls in Older PersonsJournal of the American Geriatrics Society, 2001
- Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode SchizophreniaAmerican Journal of Psychiatry, 2000
- Weight gain associated with psychotropic drugsExpert Opinion on Pharmacotherapy, 2000
- Tardive dyskinesia and atypical antipsychotic drugsSchizophrenia Research, 1999
- Comparison of Risperidone and Placebo for Psychosis and Behavioral Disturbances Associated With DementiaThe Journal of Clinical Psychiatry, 1999
- Radioreceptor Binding Profile of the Atypical Antipsychotic OlanzapineNeuropsychopharmacology, 1996
- Diabetes mellitus in schizophrenic patientsComprehensive Psychiatry, 1996
- Risk of Tardive Dyskinesia in Older PatientsArchives of General Psychiatry, 1995
- Obesity, Weight Loss and Prognosis in Type 2 DiabetesDiabetic Medicine, 1990